sacituzumab govitecan
gilead sciences
['mbc', 'sacituzumab']
sacituzumab govitecan, an antibody drug conjugate, demonstrated improved pfs over ct in patients with endocrine-resistant hr+/her2- mbc. #asco22 
MDedge Hematology & Oncology provides the most important and up to date information and news for oncologists. Now part of the Medscape Professional Network.